Reporting of Hybrid Cardiac SPECT/CT and PET/CT Studies
| Report parameter | Details |
| Indication for test | For both the MPI and the CT studies |
| History | Prior coronary artery disease or coronary procedures |
| Current medications | Listing of all |
| Methods | Technique for the MPI study, stress study, and CT study |
| MPI | Type and dose of injected radiotracer; type of imaging technique (SPECT or PET); type of attenuation correction, if performed; details of stress testing modality; hemodynamic and electrocardiographic changes |
| CT | Technique for attenuation correction CT, coronary artery calcium score, and coronary CTA, if applicable |
| Doses of β-blocker/nitroglycerin for coronary CTA, if used | |
| Coronary CTA methods (Table 9) | |
| Findings | Nongated MPI findings |
| Gated MPI findings | |
| Coronary artery calcium score (overall Agatston score and percentile ranking based on age and sex) | |
| Coronary CTA details (Table 9) | |
| Ancillary findings (for MPI, CTAC, coronary artery calcium score, and coronary CTA, if applicable) | |
| Summary | Impression of MPI findings |
| Impression of CT findings (especially for coronary artery calcium score and coronary CTA) | |
| Integration of MPI and CT findings (especially for coronary artery calcium score and coronary CTA) | |
| Explanations for discordant findings | |
| Localization of disease to vascular territory |
CTA = CT angiogram; MPI = myocardial perfusion imaging; CTAC = CT for attenuation correction.